Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
They set the ipo process at a surprising $12, we'll below the projected $15-$17 range. Looks like it could be a great opportunity for a financially strong company. Thoughts?
LMNS provides energy-based, minimally invasive clinical solutions primarily for the aging population.
It has established a strong brand across diverse end-markets, consisting of its surgical, ophthalmic and aesthetic segments.
Income statement metrics:
2013 revenue was up 6.4% versus 2012 to $265 million.
Gross profit was 54% and increased 15.4% to $142 million.
Operating income increased 175% to $26 million.
After tax income increased $149% to $17 million, but the tax rate was only 14%.
LMNS believes that its focus on product development has resulted in its strongest pipeline of new products and applications in over a decade.